Catalyst OrthoScience
-
Extremities
Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
NAPLES, Fla., November 20, 2023–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has…
Read More » -
Recon
Research Published in JSES Indicates that the Catalyst™ CSR Total Shoulder System Outperforms Traditional Stemmed Implants
March 6, 2023 NAPLES, Fla.–(BUSINESS WIRE)– Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market,…
Read More » -
Recon
Catalyst Receives FDA 510(k) Clearance for its Convertible Stemmed Total Shoulder Arthroplasty System
Catalyst is first-to-market with a fully convertible system that features an ellipsoid anatomic head February 9, 2023 NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience…
Read More » -
Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education and Training
May 18, 2022 NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased…
Read More » -
Recon
Catalyst OrthoScience Announces David Sharp as Vice President of Global Marketing
April 12, 2022 NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased…
Read More » -
Extremities
Catalyst OrthoScience Features Innovative Products and Shoulder Surgery Leaders at AAOS
Visit booth #2408 for product demonstrations of the Archer™ Shoulder Systems March 22, 2022 NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (Catalyst), a…
Read More » -
Extremities
Archer™ Shoulder Systems Presented, Catalyst OrthoScience Showcasing Innovative Products at Upcoming Orthopedic Events
Demos of the Archer™ Shoulder Systems will be available at the 2021 Ortho Summit and the 2021 ASES Annual Meeting…
Read More » -
Recon
Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System
NAPLES, Fla., April 28, 2021 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, is…
Read More » -
Recon
Catalyst OrthoScience receives FDA 510(K) clearance of its reverse shoulder system
Reverse system allows Catalyst to address vast majority of shoulder arthroplasty market; Limited user release expected in Q2 2021 NAPLES,…
Read More » -
Extremities
Newly Published Study With the Stemless Catalyst CSR™ Total Shoulder System Demonstrates Good Results in Adult Arthroplasty Patients of All Ages at 2-3 Year Follow-Up
Retrospective case series published in the Journal of Shoulder and Elbow Surgery examines 63 shoulders in patients up to 85…
Read More »